logo

22.56

22.56 (0.83%)

As of Mar 06, 2024

Cabaletta Bio, Inc. [CABA]

Source: 

Company Overview

Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases.

CountryUnited States
Headquartersphiladelphiapennsylvania
Phone Number(267) 759-3100
Industry
manufacturing
CEOSteven Nichtberger
Websitewww.cabalettabio.com